Supportive effect of body contact care with ylang ylang aromatherapy and mobile intervention team for suicide prevention: A pilot study.

Polynesia anxiety aromatherapy depression mobile intervention prevention suicide ylang ylang

Journal

The Journal of international medical research
ISSN: 1473-2300
Titre abrégé: J Int Med Res
Pays: England
ID NLM: 0346411

Informations de publication

Date de publication:
Sep 2020
Historique:
entrez: 5 9 2020
pubmed: 5 9 2020
medline: 15 5 2021
Statut: ppublish

Résumé

To assess understudied, alternative suicide prevention modalities in a mental health care setting. This was a prospective study of patients (n = 140, 68 cases and 72 controls) who were admitted to hospital or who contacted an SOS suicide crisis line for suicidal ideation or attempts. Psychiatric diagnoses (Mini-International Neuropsychiatric Interview) and intensity of anxiety/depression/suicidality (Hamilton Anxiety Rating Scale, Montgomery-Åsberg Depression Rating Scale, and Beck Scale for Suicidal Ideation) were assessed. All intervention group subjects received a crisis card with a crisis line number, interviews with psychologists or volunteers and a telephone call on days 10 to 21, then 6 months later. These subjects also had a choice between two further 4-month interventions: body contact care or mobile intervention team visits. The interventions significantly reduced the number of suicide attempts and suicide (3%) at 6 months compared with the control condition (12%). There were fewer losses to follow-up in the intervention group (7.35%) than in the control group (9.72%). The results favour the implementation of integrated care and maintaining contact in suicide prevention.

Identifiants

pubmed: 32883150
doi: 10.1177/0300060520946237
pmc: PMC7479860
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

300060520946237

Commentaires et corrections

Type : ErratumIn

Références

Psychiatr Serv. 2001 Jun;52(6):828-33
pubmed: 11376235
Psychiatry Res. 2006 Nov 29;145(1):21-37
pubmed: 17049379
Psychiatry Res. 2015 Feb 28;225(3):368-73
pubmed: 25571773
Am J Psychiatry. 2016 Nov 1;173(11):1094-1100
pubmed: 27523496
J Clin Psychiatry. 2010 Mar;71(3):313-26
pubmed: 20331933
JAMA Psychiatry. 2018 Sep 1;75(9):894-900
pubmed: 29998307
Bull World Health Organ. 2008 Sep;86(9):703-9
pubmed: 18797646
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
BMJ Open. 2018 Oct 23;8(10):e022762
pubmed: 30355792
J Affect Disord. 1988 Jan-Feb;14(1):61-8
pubmed: 2963053
Br J Psychiatry. 2015 Mar;206(3):184-90
pubmed: 25733570
Health Qual Life Outcomes. 2017 May 8;15(1):95
pubmed: 28482849
Int J Neurosci. 2006 Dec;116(12):1447-55
pubmed: 17145679
J Adv Pharm Technol Res. 2013 Jul;4(3):134-40
pubmed: 24083200
Phytomedicine. 2002 Dec;9(8):721-6
pubmed: 12587692
Crisis. 2010;31(4):194-201
pubmed: 20801749
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
J Clin Psychiatry. 2018 Sep 25;79(6):
pubmed: 30256552
J Altern Complement Med. 2013 Apr;19(4):334-40
pubmed: 23098696
J Affect Disord. 2016 Jan 1;189:351-6
pubmed: 26476419
Ment Illn. 2015 Oct 09;7(2):5818
pubmed: 26605034
Br J Psychiatry. 2007 Dec;191:548-53
pubmed: 18055960
J Int Med Res. 2019 Oct;47(10):5130-5145
pubmed: 31510825
Rev Psiquiatr Salud Ment. 2018 Apr - Jun;11(2):86-93
pubmed: 27914883
J Psychiatr Res. 2006 Apr;40(3):243-6
pubmed: 15979643
Encephale. 2019 Jan;45 Suppl 1:S27-S31
pubmed: 30551792
Lancet Psychiatry. 2014 Aug;1(3):193-201
pubmed: 26360731
Br J Psychiatry. 2002 Sep;181:226-9
pubmed: 12204927
BMC Fam Pract. 2018 Jan 24;19(1):19
pubmed: 29368585
J Clin Oncol. 2007 Feb 10;25(5):532-9
pubmed: 17290062
Acad Emerg Med. 2010 Jan;17(1):36-43
pubmed: 20015106
Complement Ther Nurs Midwifery. 2003 May;9(2):90-7
pubmed: 12697161
Complement Ther Clin Pract. 2014 Nov;20(4):224-9
pubmed: 25172313
Br J Med Psychol. 1959;32(1):50-5
pubmed: 13638508
Complement Ther Med. 2010 Feb;18(1):1-7
pubmed: 20178872
BMJ. 2006 May 27;332(7552):1241-5
pubmed: 16735333
Br J Gen Pract. 2000 Jun;50(455):493-6
pubmed: 10962794
Phytother Res. 2006 Sep;20(9):758-63
pubmed: 16807875

Auteurs

Stéphane Amadéo (S)

Centre hospitalier de Polynésie française (CHPF), & Maison des Sciences de l'Homme du Pacifique (USR 2003, UPF / CNRS) Tahiti, Polynésie française (SA), Tahiti, Polynésie française, France.
Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.
Inserm, Équipe Moods-IPSOM, CESP, 94807, Villejuif, France.

Ngoc Lam Nguyen (NL)

Centre hospitalier de Polynésie française (CHPF), & Maison des Sciences de l'Homme du Pacifique (USR 2003, UPF / CNRS) Tahiti, Polynésie française (SA), Tahiti, Polynésie française, France.
Direction de la santé publique de la Polynésie française, Tahiti, Polynésie française, France.

Taivini Teai (T)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.
Université de Polynésie française (UPF), Tahiti, Polynésie française, France.

Patrick Favro (P)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.
Université de Polynésie française (UPF), Tahiti, Polynésie française, France.

Aurélia Mulet (A)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Nathalie Colin-Fagotin (N)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Moerani Rereao (M)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Aurélia Malogne (A)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Michel De Simone (M)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Géraldine Rioche (G)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Virginie Gassion (V)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Paul Pere (P)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Alban Prokop (A)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Fabienne Bernis (F)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Pierre Dufour (P)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Annie Tuheiava (A)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Germaine Vanquin (G)

Centre de prévention du suicide (SPC), SOS Suicide NGO, Tahiti, Polynésie française, France.

Steve Vilhem (S)

Service universitaire de psychiatrie de l'enfant et de l'adolescent (SUPEA), centre hospitalier universitaire Vaudois (CHUV), Lausanne, Switzerland.

Erick Gokalsing (E)

Inserm, Équipe Moods-IPSOM, CESP, 94807, Villejuif, France.
CUMP Océan Indien/VigilanS Océan Indien Etablissement Public de Santé Mentale, La Réunion, France.

Michel Spodenkiewicz (M)

Inserm, Équipe Moods-IPSOM, CESP, 94807, Villejuif, France.
Pôle de Santé Mentale, CIC-EC 1410, CHU de la Réunion, Saint-Pierre, France.

Marianne Pradem (M)

Inserm, Équipe Moods-IPSOM, CESP, 94807, Villejuif, France.

Monique Seguin (M)

Groupe McGill d'Étude sur le Suicide. Réseau québécois de recherche sur le suicide, la dépression et les troubles associés (Rqsdta), Université McGill -- Institut Universitaire en Santé Mentale de l'Hôpital Douglas, Canada.

Guy Beauchamp (G)

Groupe McGill d'Étude sur le Suicide. Réseau québécois de recherche sur le suicide, la dépression et les troubles associés (Rqsdta), Université McGill -- Institut Universitaire en Santé Mentale de l'Hôpital Douglas, Canada.

Pierre Thomas (P)

Université de Lille, Inserm, CHU Lille, U1172 -- Lille Neuroscience & Cognition et Centre National de Ressource et Résilience pour les psychotraumatismes (Cn2r Lille Paris), F-59000 Lille, France.

Guillaume Vaiva (G)

Université de Lille, Inserm, CHU Lille, U1172 -- Lille Neuroscience & Cognition et Centre National de Ressource et Résilience pour les psychotraumatismes (Cn2r Lille Paris), F-59000 Lille, France.

Louis Jehel (L)

Inserm, Équipe Moods-IPSOM, CESP, 94807, Villejuif, France.
Université des Antilles, Campus de Schoelcher, BP 7029, 97275 Schoelcher. Université Paris-Saclay, UVSQ & Université Paris-Sud. Centre Hospitalier Universitaire de Martinique, BP632, 97261 Cedex Fort de France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH